Zoledronic Acid, Hypocalcemia and Renal Dysfunction in Thalidomide-Treated Myeloma Patients

Reviewer: Walter Sall, MD
OncoLink
Ultima Vez Modificado: 10 de diciembre del 2002

Translation for this article does not exist